Biotechnology Analysis & Statistics, July 2014 (p20)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: biotech, protein, biomedical, more »

571-600 of about 2 400 reports

Purchase Reports From Reputable Market Research Publishers

International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company. The company develops parthenogenesis, a stem cell technology that advances the field of regenerative medicine. It develops ...

  • Industries : Biological Therapy
  • Countries : India, United States
OncoMed Pharmaceuticals, Inc. (OMED) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

OncoMed Pharmaceuticals, Inc. (OMED) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary OncoMed Pharmaceuticals, Inc. (OncoMed) is a biotechnology company. The company discovers and develops monoclonal antibody therapeutics. Its product pipeline includes demcizumab, OMP-59R5, vantictumab, ...

  • Industries : Genomics
  • Countries : United States
Kythera Biopharmaceuticals, Inc. (KYTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kythera Biopharmaceuticals, Inc. (KYTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Kythera Biopharmaceuticals, Inc. (Kythera) is a biopharmaceutical company. The company discovers, develops and commercializes prescription products for the aesthetic medicine market. Its pipeline ...

  • Industries : Biopharmaceutical
  • Countries : United States
Microbix Biosystems Inc. (MBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Microbix Biosystems Inc. (MBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Microbix Biosystems Inc. (Microbix) is a biotechnology service provider. The company develops biological products and technologies. Its products include chlamydia trachomatis, chlamydophila pneumoniae, ...

  • Industries : Biotechnology
  • Countries : Canada
Immuron Limited (IMC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Immuron Limited (IMC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Immuron Limited (Immuron) is a biopharmaceutical company. The company conducts research and develops polyclonal antibody products for humans. Its products include Travelan, IMM-272, IMM 124-E, ...

  • Industries : Biopharmaceutical
NanoCarrier Co., Ltd. (4571) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NanoCarrier Co., Ltd. (4571) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary NanoCarrier Co., Ltd. (NanoCarrier) is a biotechnology company. The company researches, develops and produces pharmaceuticals using micellar nanoparticles technology. It develops drugs in the field ...

  • Industries : Biotechnology
  • Countries : Japan
Gene Techno Science Co., Ltd. (4584) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Gene Techno Science Co., Ltd. (4584) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Gene Techno Science Co., Ltd. (GTS) is a biotechnology company. The company develops and markets drug and antibodies for intractable diseases and rare diseases. Its products include GND-001, GND-002, ...

  • Industries : Biopharmaceutical
Medicamen Biotech Ltd. (531146) - Financial and Strategic SWOT Analysis Review

Medicamen Biotech Ltd. (531146) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • July 2014
  • by Global Data

Medicamen Biotech Ltd. (531146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Biotechnology
PharmAthene, Inc. (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PharmAthene, Inc. (PIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary PharmAthene, Inc. (PharmAthene) is a pharmaceutical company. The company develops and commercializes medical counter measures to biological and chemical weapons. Its products include recombinant ...

  • Industries : Biopharmaceutical
  • Countries : United States
Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments ...

  • Industries : Biological Therapy
TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TapImmune Inc. (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary TapImmune Inc. (TapImmune) is a biotechnology company. The company develops peptide and gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease. Its immunotherapy ...

  • Industries : Biopharmaceutical
  • Countries : United Kingdom, United States
Transgene Biotek Limited (526139) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transgene Biotek Limited (526139) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Transgene Biotek Limited (Transgene) is a biotechnology company. The company develops and commercializes biogeneric drugs and biotech products. Its activities include research and development of ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : World
Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transgene SA (TNG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Transgene SA (Transgene) is a biopharmaceutical company. The company designs and develops immunotherapeutic products to treat cancers and chronic infectious diseases. It works with all stages of ...

  • Industries : Genetically Modified Organism, Gmo
UMN Pharma Inc. (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

UMN Pharma Inc. (4585) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary UMN Pharma Inc. (UMN) is a biopharmaceutical company. The company develops vaccines to cure diabetes, muscular dystrophy and influenza. Its products include UMN-0502, UMN-0501, UMN-0901 and UMN-2003. ...

  • Industries : Biopharmaceutical
Versartis, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Versartis, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Versartis, Inc. (Versartis) is a biopharmaceutical company. It develops therapeutic proteins for the treatment of endocrine disorders. The company's product pipeline includes VRS-317, a human growth ...

  • Industries : Biopharmaceutical
  • Countries : United States
Pharmicell Co., Ltd. (005690) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmicell Co., Ltd. (005690) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Pharmicell Co., Ltd. (Pharmicell) is a biotechnology company. The company develops and commercializes stem cell therapeutics for incurable diseases such as cancer, brain and nervous system disorde ...

  • Industries : Biological Therapy
Viropro Inc. (VPRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Viropro Inc. (VPRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Viropro, Inc. (Viropro) is a pharmaceutical company. The company develops and manufactures therapeutic monoclonal antibodies. Its products include Rituximab, Trastuzumab, Infliximab, Etanercept ...

  • Industries : Biopharmaceutical
  • Countries : United States
Sygnis AG (LIO1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sygnis AG (LIO1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Sygnis AG (SYGNIS), formerly SYGNIS Pharma AG, is a biopharmaceutical company. It is focused on the development of novel products and tools in the fields of molecular biology for the fast-growing ...

  • Industries : Genomics
Merger & Acquisition in Medical Equipment Industry: QuantRx Biomedical Corporation (QTXB)

Merger & Acquisition in Medical Equipment Industry: QuantRx Biomedical Corporation (QTXB)

  • $ 250
  • Company report
  • July 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Rosetta Genomics, Ltd. (ROSG) - Medical Equipment - Deals and Alliances Profile

Rosetta Genomics, Ltd. (ROSG) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Rosetta Genomics, Ltd. (RGL) is a biotechnology company. The company discovers, develops and commercializes next generation diagnostic tests for personalized medicine. It provides testing services ...

  • Industries : Genomics
  • Countries : United States
Response Genetics, Inc. (RGDX) - Medical Equipment - Deals and Alliances Profile

Response Genetics, Inc. (RGDX) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Response Genetics, Inc. (RGI) is a molecular diagnostic company. The company develops technology for the extraction and analysis of genetic information. It has tests and panels for lung, gastric, ...

  • Industries : Genomics
  • Countries : United States
BioChips & BioMEMS 2014

BioChips & BioMEMS 2014

  • $ 2 450
  • Industry report
  • July 2014
  • by Dedalus Consulting

BioChips & BioMEMS (Bio Microelectromechanical Systems)-World Markets, Applications & Opportunities: 2013-2018 Analysis & Forecasts A detailed report analyzing current trends in the dynamic and growing ...

  • Industries : Genomics
  • Countries : World
Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

  • Industries : Biological Therapy
Antibodies in Oncology Drug Pipeline Update 2014

Antibodies in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the ...

  • Industries : Biopharmaceutical
Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

There are today 120 companies plus partners developing 107 gene therapy drugs in 276 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...

  • Industries : Biological Therapy
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 332 companies plus partners developing 441 Androgen Receptor drugs in 1457 developmental projects in cancer. ...

  • Industries : Biological Therapy
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-recepto ...

  • Industries : Biological Therapy
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The EGFR1 signaling pathway activates the Ras/Raf/MAPK signaling modules. There are today 371 companies plus partners developing 642 EGFR1 pathway targeting drugs in 2397 developmental projects in cancer. ...

  • Industries : Biological Therapy
Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Aberrant activation of the Hedgehog pathway has been associated with a number of human malignancies including carcinoma of lung, esophagus, pancreas and prostate. There are today 119 companies plus partners ...

  • Industries : Biological Therapy
ID Signaling Pathway in Oncology Drug Pipeline Update 2014

ID Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 749
  • Industry report
  • July 2014
  • by Bioseeker

Inhibitor of DNA binding (ID) proteins are members of the helix-loop-helix (HLH) family of proteins which lack a DNA binding domain themselves but bind to other family members inhibiting their DNA binding ...

  • Industries : Biological Therapy

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Primary Sources

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.